AIMS/HYPOTHESIS: The metabolic syndrome is associated with proinflammatory and prothrombotic states. This study was designed to assess the behaviour of soluble CD40 ligand (sCD40L) and prothrombin fragment F (1+2), a marker of thrombin generation, in patients with the metabolic syndrome. METHODS: We investigated 106 patients with the metabolic syndrome, diagnosed according to the ATPIII report, and 104 subjects without the metabolic syndrome. RESULTS: Plasma values of sCD40L and F (1+2) were higher in patients with the metabolic syndrome (4.11+/-1.64 vs 2.61+/-0.89 ng/ml and 1.54+/-0.49 vs 0.87+/-0.21 nmol/l, respectively; p < 0.001) and were significantly correlated (r = 0.925, p < 0.001). Stepwise multiple linear regression analysis showed that sCD40L was significantly associated with F (1+2), female sex and waist circumference. CONCLUSIONS/ INTERPRETATION: Patients with the metabolic syndrome have enhanced values of plasma sCD40L and F (1+2). The study provides further insight into the relationship between metabolic syndrome, inflammation and thrombosis.
AIMS/HYPOTHESIS: The metabolic syndrome is associated with proinflammatory and prothrombotic states. This study was designed to assess the behaviour of soluble CD40 ligand (sCD40L) and prothrombin fragment F (1+2), a marker of thrombin generation, in patients with the metabolic syndrome. METHODS: We investigated 106 patients with the metabolic syndrome, diagnosed according to the ATPIII report, and 104 subjects without the metabolic syndrome. RESULTS: Plasma values of sCD40L and F (1+2) were higher in patients with the metabolic syndrome (4.11+/-1.64 vs 2.61+/-0.89 ng/ml and 1.54+/-0.49 vs 0.87+/-0.21 nmol/l, respectively; p < 0.001) and were significantly correlated (r = 0.925, p < 0.001). Stepwise multiple linear regression analysis showed that sCD40L was significantly associated with F (1+2), female sex and waist circumference. CONCLUSIONS/ INTERPRETATION:Patients with the metabolic syndrome have enhanced values of plasma sCD40L and F (1+2). The study provides further insight into the relationship between metabolic syndrome, inflammation and thrombosis.
Authors: G Dangas; D A Smith; J J Badimon; A H Unger; J H Shao; P Meraj; A M Cohen; D Levine; J T Fallon; J A Ambrose Journal: Am J Cardiol Date: 1999-09-15 Impact factor: 2.778
Authors: John K Ninomiya; Gilbert L'Italien; Michael H Criqui; Joanna L Whyte; Anthony Gamst; Roland S Chen Journal: Circulation Date: 2003-12-15 Impact factor: 29.690
Authors: Subodh Verma; Shu-Hong Li; Chao-Hung Wang; Paul W M Fedak; Ren-Ke Li; Richard D Weisel; Donald A G Mickle Journal: Circulation Date: 2003-07-21 Impact factor: 29.690
Authors: Cynthia J Girman; Thomas Rhodes; Michele Mercuri; Kalevi Pyörälä; John Kjekshus; Terje R Pedersen; Polly A Beere; Antonio M Gotto; Michael Clearfield Journal: Am J Cardiol Date: 2004-01-15 Impact factor: 2.778
Authors: Anna Deskur; Daria Sałata; Marta Budkowska; Barbara Dołęgowska; Teresa Starzyńska; Wojciech Błogowski Journal: Am J Transl Res Date: 2014-11-22 Impact factor: 4.060
Authors: Ilkay Tugba Unek; Firat Bayraktar; Dilek Solmaz; Hulya Ellidokuz; Ali Riza Sisman; Faize Yuksel; Sena Yesil Journal: Clin Med Res Date: 2010-07
Authors: M Poggi; J Jager; O Paulmyer-Lacroix; F Peiretti; T Gremeaux; M Verdier; M Grino; A Stepanian; S Msika; R Burcelin; D de Prost; J F Tanti; M C Alessi Journal: Diabetologia Date: 2009-01-31 Impact factor: 10.122
Authors: Marina C Dos Santos Moreira; Izabella S de Jesus Pinto; Aline A Mourão; James O Fajemiroye; Eduardo Colombari; Ângela A da Silva Reis; André H Freiria-Oliveira; Marcos L Ferreira-Neto; Gustavo R Pedrino Journal: Front Physiol Date: 2015-08-25 Impact factor: 4.566